Immunic, Inc

1200 Avenue of the Americas, Suite 200
New York, NY 10036, USA

Phone: +49 89 2080 477 00
Email: info@imux.com

Immunic AG

Lochhamer Schlag 21
82166 Gräfelfing, Germany

Phone: +49 89 2080 477 00
Email: info@imux.com

Publications

Publications

Presentation

Virtual R&D Day: Update on the Preclinical and Clinical Development of IMU-935

July 12, 2021

Play Audio Recording

Poster Presentation

The International Federation of Psoriasis Association’s 6th World Psoriasis & Psoriatic Arthritis Conference 2021

Wednesday, June 30, 2021 – Saturday, July 3, 2021

Presentation

IMU-838 in Multiple Sclerosis: Phase 3 Program in RRMS & Phase 2 Trial in PMS

July 1, 2021

Play Audio Recording

Poster Presentation

2021 Virtual AAN Annual Meeting

Saturday, April 17, 2021 – Thursday, April 22, 2021

Play Audio Recording

Poster Presentation

30th Annual Meeting of the Society for Virology

Wednesday, March 24, 2021 – Friday, March 26, 2021

Presentation

Main Phase 2 Analysis IMU-838 in Moderate COVID-19 & Phase 2 Proof-of-Concept Study IMU-838 in PSC

February 18, 2021

Play Audio Recording

Article

Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases

Andreas Muehler, Jason R Slizgi, Hella Kohlhof, Manfred Groeppel, Evelyn Peelen and Daniel Vitt
World Journal of Gastrointestinal Pathophysiology; 2020 December 12; 11(6):114-130
Published: December 12, 2020
doi: 10.4291/wjgp.v11.i6.114

Article

IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro

Friedrich Hahn, Christina Wangen, Sigrun Häge, Antonia Sophia Peter, Gerhard Dobler, Brett Hurst, Justin Julander, Jonas Fuchs, Zsolt Ruzsics, Klaus Überla, Hans-Martin Jäck, Roger Ptak, Andreas Muehler, Manfred Gröppel, Daniel Vitt, Evelyn Peelen, Hella Kohlhof and Manfred Marschall
Viruses 2020, 12, 1394
Published: December 5, 2020
doi: 10.3390/v12121394

Poster Presentation

MSVirtual2020 / 8th Joint ACTRIMS-ECTRIMS Meeting

Friday, September 11, 2020 – Sunday, September 13, 2020

Presentation

IMU-838 Phase 2 Data EMPhASIS Trial in RRMS

September 11, 2020

Play Audio Recording

Presentation

IMU-838 Phase 2 Top-Line Data EMPhASIS Trial in RRMS

August 3, 2020

Article

Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro

Yu-Jin Kim, Beatrice Cubitt, Yingyun Cai, Jens H. Kuhn, Daniel Vitt, Hella Kohlhof, Juan C. de la Torre
Viruses 2020, 12, 821
Published: July 29, 2020
doi: 10.3390/v12080821

Presentation

Immunic’s Inaugural Virtual R&D Day

May 19, 2020

Play Audio Recording

Article

Vidofludimus calcium, a next generation DHODH inhibitor for the treatment of relapsing-remitting multiple sclerosis

Andreas Muehler, Evelyn Peelen, Hella Kohlhof, Manfred Gröppel, Daniel Vitt
Multiple Sclerosis and Related Disorders, Volume 43, 2020
Published online: May 6, 2020
ISSN 2211-0348 / doi: 10.1016/j.msard.2020.102129

Article

Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects

Andreas Muehler, Hella Kohlhof, Manfred Groeppel & Daniel Vitt
European Journal of Drug Metabolism and Pharmacokinetics
Published online: May 2, 2020
ISSN 0378-7966 / doi: 10.1007/s13318-020-00623-7

Abstract

Design, Rationale and Baseline Characteristics of the Randomized Double-blind Phase II Clinical Trial of Vidofludimus calcium (IMU-838) in Relapsing-Remitting Multiple Sclerosis (4558)

Robert Fox, Heinz Wiendl, Nicola De Stefano, Johann Sellner, Andreas Mühler
Neurology Apr 2020, 94 (15 Supplement) 4558
Published online: April 14, 2020

Presentation

IBD Innovate Conference: Product Development for Crohn’s and Colitis

Wednesday, December 4, 2019
New York

Poster Presentation

United European Gastroenterology Week (UEGW)

Tuesday, October 22, 2019
Barcelona, Spain

Article

The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study

Andreas Muehler, Hella Kohlhof, Manfred Groeppel & Daniel Vitt
Drugs in R&D
Published online: October 16, 2019
ISSN 1174-5886 / doi: 10.1007/s40268-019-00286-z

Poster Presentation

Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2019

Wednesday, September 11, 2019
Stockholm, Sweden

Presentation

GI Inflammatory Diseases Summit (GIIDS)

Monday, June 24, 2019
Boston

Poster Presentation

2nd Conference on Molecular Mechanisms of Inflammation

Tuesday, June 4, 2019
Trondheim, Norway